What’s in line for India’s transcatheter aortic valve replacement market?

A high burden of heart valve diseases is driving its expansion.

India’s transcatheter aortic valve replacement (TAVR) market is projected to grow at a compound annual growth rate of around 24% until 2033, driven by a high burden of heart valve diseases, said GlobalData.

Conditions like rheumatic heart disease and degenerative aortic stenosis are driving the sector’s expansion, further exacerbated by socioeconomic challenges and limited healthcare access.

Despite the growing demand, India accounted for only around 3% of the Asia-Pacific market in 2024. The limited availability and high costs of TAVR procedures, alongside competition from established players, have constrained wider adoption.

“Challenges remain in achieving consistent and accurate valve placement, especially in patients with complex anatomy, which can lead to paravalvular leaks,” Shreya Jain, Medical Devices Analyst at GlobalData, said.

“Increased affordability and accessibility, coupled with growing awareness and ongoing research, will be key to the expansion of the TAVR market in India,” Jain added.